Tue, Jun 18, 2013, 9:34 PM EDT - U.S. Markets closed
Smart move, take the ILMN bid off the table and never, never overpay, especially in this market. There will be a much better price later.
Illumina is going to present a tender offer bid to Pacific Biosciences. I don't think they'll offer much though. Slight premium only.
ILMN was a steal at $66 dummy. You really really really don't know what you are talking about.
KIRK will sell TBIO to ROCHE and HALOZYME might get taken out by Pfizer, HALO at JPM!